Akero Therapeutics, Inc. (AKRO)
NASDAQ: AKRO · Real-Time Price · USD
31.73
+2.02 (6.80%)
Oct 29, 2024, 4:00 PM EDT - Market closed
Akero Therapeutics Market Cap
Akero Therapeutics has a market cap or net worth of $2.20 billion as of October 29, 2024. Its market cap has increased by 170.81% in one year.
Market Cap
2.20B
Enterprise Value
1.39B
1-Year Change
170.81%
Ranking
Category
Stock Price
$31.73
Market Cap Chart
Since June 20, 2019, Akero Therapeutics's market cap has increased from $481.70M to $2.20B, an increase of 357.35%. That is a compound annual growth rate of 32.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2024 | 2.06B | 58.58% |
| Dec 29, 2023 | 1.30B | -49.24% |
| Dec 30, 2022 | 2.56B | 247.28% |
| Dec 31, 2021 | 737.90M | -17.63% |
| Dec 31, 2020 | 895.80M | 41.32% |
| Dec 31, 2019 | 633.90M | 31.60% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Structure Therapeutics | 2.14B |
| UFP Technologies | 2.14B |
| Privia Health Group | 2.12B |
| Belite Bio | 2.08B |
| Ligand Pharmaceuticals | 2.07B |
| Warby Parker | 2.06B |
| Azenta | 2.05B |
| Harmony Biosciences Holdings | 2.03B |